Article Type
Changed
Tue, 10/23/2018 - 16:12
Display Headline
From the EVP/CEO: Focused on our international initiatives

CHEST is committed to being the global leader in clinical chest medicine. Our vision affirms it: CHEST is the global leader in advancing best patient outcomes through innovative chest medicine education, clinical research, and team-based care. Our organization is a diverse community of experts and peers, representing more than 100 countries, giving us ample opportunity to collaborate and advance chest medicine around the world. Recently, we reviewed our international work to ensure we’re meeting education needs and fulfilling leadership responsibilities around the world. I’m happy to say we’re in good standing on both counts.

Paul A. Markowski, CAE

To be effective and efficient in our international education offerings, we have identified premier programs and products that readily allow us to share the CHEST brand and reputation across the globe. We offer standardized delivery and execution to ensure everyone receives the same high-quality CHEST experience. These programs include:

• CHEST live learning events, held in international locations

CHEST journal-branded meetings

• Grant partnerships for international fellows

• Captured content from live events

Our live learning events are scalable to accommodate larger or smaller meetings, enabling them to be delivered across multiple locations and countries. We invite CHEST leadership and faculty to collaborate with local partners to provide expertise and lead sessions. Similarly, CHEST journal-branded meetings, developed and held in partnership with our journal publisher Elsevier, offer the same value and benefits as our live learning events. Content can focus on a specific disease state or have a broader topic reach. Journal editors or associate editors and top researchers are available to assist by serving as faculty. Both these options mean CHEST-branded education is accessible around the world.

CHEST leaders participated in a February meeting of the Forum of International Respiratory Societies (FIRS) in Kyoto, Japan, along with representatives from Asociación Latinoamericana del Thorax (ALAT), the American Thoracic Society (ATS), the Asian Pacific Society of Respirology (APSR), the European Respiratory Society (ERS), the International Union Against Tuberculosis and Lung Disease (The Union), and the Pan African Thoracic Society (PATS). Established in 2001, the forum aims to promote advocacy in matters of global respiratory health and the identification of new areas for global initiatives. CHEST leaders attending included Dr. Darcy Marciniuk, FCCP; Dr. Barbara Phillips, FCCP; and Mr. Paul Markowski (3rd, 4th, and 5th from right, respectively).

In addition to bringing our programs to international audiences, we’re also able to bring international audiences to our programs, specifically to CHEST Annual Meeting and CHEST World Congress. Grant partnership opportunities are extended to sponsoring organizations that wish to cover registration, travel, housing, and per-diem living expenses for international fellows. As part of the program, we assign a CHEST liaison to each sponsored physician to further enhance his or her meeting experience. Again, this program makes CHEST-branded education more accessible throughout the world.

Knowing health-care professionals aren’t always able to travel to our events, we capture education content to make it available on demand. We have hundreds of sessions from our CHEST Annual Meeting and CHEST Board Review available for purchase in the CHEST store at chestnet.org/store. Or, international partners can license this content, and provide it to health-care professionals in their areas. Both options extend the reach of our education programs to those who may not be able to participate in a live event.

On the leadership front, we continue to lead the promotion of lung health awareness around the world. A founding member of the Forum of International Respiratory Societies (FIRS), we work with the world’s leading respiratory societies to improve lung health globally. Our initiatives to date include declaring 2016 to 2025 as the Decade of the Lung and engaging organizations to improve lung health through prevention efforts. Under the Decade of the Lung umbrella, FIRS organizations brought awareness to the need for pneumonia prevention and stronger management strategies. More recently, CHEST participated with FIRS to raise global concerns of lung cancer on World Cancer Day, February 2.

As an established and recognized leader in chest medicine, CHEST is in an ideal position to advance lung health around the world. This is an opportunity we take seriously and will continue to focus on meeting our vision.

If you have thoughts or ideas about how we can enhance our work to be a global leader in chest medicine, feel free to connect with me. I invite you to follow me on Twitter (@PMarkowskiACCP), or look for me at upcoming CHEST events.

References

Author and Disclosure Information

Publications
Sections
Author and Disclosure Information

Author and Disclosure Information

CHEST is committed to being the global leader in clinical chest medicine. Our vision affirms it: CHEST is the global leader in advancing best patient outcomes through innovative chest medicine education, clinical research, and team-based care. Our organization is a diverse community of experts and peers, representing more than 100 countries, giving us ample opportunity to collaborate and advance chest medicine around the world. Recently, we reviewed our international work to ensure we’re meeting education needs and fulfilling leadership responsibilities around the world. I’m happy to say we’re in good standing on both counts.

Paul A. Markowski, CAE

To be effective and efficient in our international education offerings, we have identified premier programs and products that readily allow us to share the CHEST brand and reputation across the globe. We offer standardized delivery and execution to ensure everyone receives the same high-quality CHEST experience. These programs include:

• CHEST live learning events, held in international locations

CHEST journal-branded meetings

• Grant partnerships for international fellows

• Captured content from live events

Our live learning events are scalable to accommodate larger or smaller meetings, enabling them to be delivered across multiple locations and countries. We invite CHEST leadership and faculty to collaborate with local partners to provide expertise and lead sessions. Similarly, CHEST journal-branded meetings, developed and held in partnership with our journal publisher Elsevier, offer the same value and benefits as our live learning events. Content can focus on a specific disease state or have a broader topic reach. Journal editors or associate editors and top researchers are available to assist by serving as faculty. Both these options mean CHEST-branded education is accessible around the world.

CHEST leaders participated in a February meeting of the Forum of International Respiratory Societies (FIRS) in Kyoto, Japan, along with representatives from Asociación Latinoamericana del Thorax (ALAT), the American Thoracic Society (ATS), the Asian Pacific Society of Respirology (APSR), the European Respiratory Society (ERS), the International Union Against Tuberculosis and Lung Disease (The Union), and the Pan African Thoracic Society (PATS). Established in 2001, the forum aims to promote advocacy in matters of global respiratory health and the identification of new areas for global initiatives. CHEST leaders attending included Dr. Darcy Marciniuk, FCCP; Dr. Barbara Phillips, FCCP; and Mr. Paul Markowski (3rd, 4th, and 5th from right, respectively).

In addition to bringing our programs to international audiences, we’re also able to bring international audiences to our programs, specifically to CHEST Annual Meeting and CHEST World Congress. Grant partnership opportunities are extended to sponsoring organizations that wish to cover registration, travel, housing, and per-diem living expenses for international fellows. As part of the program, we assign a CHEST liaison to each sponsored physician to further enhance his or her meeting experience. Again, this program makes CHEST-branded education more accessible throughout the world.

Knowing health-care professionals aren’t always able to travel to our events, we capture education content to make it available on demand. We have hundreds of sessions from our CHEST Annual Meeting and CHEST Board Review available for purchase in the CHEST store at chestnet.org/store. Or, international partners can license this content, and provide it to health-care professionals in their areas. Both options extend the reach of our education programs to those who may not be able to participate in a live event.

On the leadership front, we continue to lead the promotion of lung health awareness around the world. A founding member of the Forum of International Respiratory Societies (FIRS), we work with the world’s leading respiratory societies to improve lung health globally. Our initiatives to date include declaring 2016 to 2025 as the Decade of the Lung and engaging organizations to improve lung health through prevention efforts. Under the Decade of the Lung umbrella, FIRS organizations brought awareness to the need for pneumonia prevention and stronger management strategies. More recently, CHEST participated with FIRS to raise global concerns of lung cancer on World Cancer Day, February 2.

As an established and recognized leader in chest medicine, CHEST is in an ideal position to advance lung health around the world. This is an opportunity we take seriously and will continue to focus on meeting our vision.

If you have thoughts or ideas about how we can enhance our work to be a global leader in chest medicine, feel free to connect with me. I invite you to follow me on Twitter (@PMarkowskiACCP), or look for me at upcoming CHEST events.

CHEST is committed to being the global leader in clinical chest medicine. Our vision affirms it: CHEST is the global leader in advancing best patient outcomes through innovative chest medicine education, clinical research, and team-based care. Our organization is a diverse community of experts and peers, representing more than 100 countries, giving us ample opportunity to collaborate and advance chest medicine around the world. Recently, we reviewed our international work to ensure we’re meeting education needs and fulfilling leadership responsibilities around the world. I’m happy to say we’re in good standing on both counts.

Paul A. Markowski, CAE

To be effective and efficient in our international education offerings, we have identified premier programs and products that readily allow us to share the CHEST brand and reputation across the globe. We offer standardized delivery and execution to ensure everyone receives the same high-quality CHEST experience. These programs include:

• CHEST live learning events, held in international locations

CHEST journal-branded meetings

• Grant partnerships for international fellows

• Captured content from live events

Our live learning events are scalable to accommodate larger or smaller meetings, enabling them to be delivered across multiple locations and countries. We invite CHEST leadership and faculty to collaborate with local partners to provide expertise and lead sessions. Similarly, CHEST journal-branded meetings, developed and held in partnership with our journal publisher Elsevier, offer the same value and benefits as our live learning events. Content can focus on a specific disease state or have a broader topic reach. Journal editors or associate editors and top researchers are available to assist by serving as faculty. Both these options mean CHEST-branded education is accessible around the world.

CHEST leaders participated in a February meeting of the Forum of International Respiratory Societies (FIRS) in Kyoto, Japan, along with representatives from Asociación Latinoamericana del Thorax (ALAT), the American Thoracic Society (ATS), the Asian Pacific Society of Respirology (APSR), the European Respiratory Society (ERS), the International Union Against Tuberculosis and Lung Disease (The Union), and the Pan African Thoracic Society (PATS). Established in 2001, the forum aims to promote advocacy in matters of global respiratory health and the identification of new areas for global initiatives. CHEST leaders attending included Dr. Darcy Marciniuk, FCCP; Dr. Barbara Phillips, FCCP; and Mr. Paul Markowski (3rd, 4th, and 5th from right, respectively).

In addition to bringing our programs to international audiences, we’re also able to bring international audiences to our programs, specifically to CHEST Annual Meeting and CHEST World Congress. Grant partnership opportunities are extended to sponsoring organizations that wish to cover registration, travel, housing, and per-diem living expenses for international fellows. As part of the program, we assign a CHEST liaison to each sponsored physician to further enhance his or her meeting experience. Again, this program makes CHEST-branded education more accessible throughout the world.

Knowing health-care professionals aren’t always able to travel to our events, we capture education content to make it available on demand. We have hundreds of sessions from our CHEST Annual Meeting and CHEST Board Review available for purchase in the CHEST store at chestnet.org/store. Or, international partners can license this content, and provide it to health-care professionals in their areas. Both options extend the reach of our education programs to those who may not be able to participate in a live event.

On the leadership front, we continue to lead the promotion of lung health awareness around the world. A founding member of the Forum of International Respiratory Societies (FIRS), we work with the world’s leading respiratory societies to improve lung health globally. Our initiatives to date include declaring 2016 to 2025 as the Decade of the Lung and engaging organizations to improve lung health through prevention efforts. Under the Decade of the Lung umbrella, FIRS organizations brought awareness to the need for pneumonia prevention and stronger management strategies. More recently, CHEST participated with FIRS to raise global concerns of lung cancer on World Cancer Day, February 2.

As an established and recognized leader in chest medicine, CHEST is in an ideal position to advance lung health around the world. This is an opportunity we take seriously and will continue to focus on meeting our vision.

If you have thoughts or ideas about how we can enhance our work to be a global leader in chest medicine, feel free to connect with me. I invite you to follow me on Twitter (@PMarkowskiACCP), or look for me at upcoming CHEST events.

References

References

Publications
Publications
Article Type
Display Headline
From the EVP/CEO: Focused on our international initiatives
Display Headline
From the EVP/CEO: Focused on our international initiatives
Sections
Article Source

PURLs Copyright

Inside the Article